Skip to content

VolitionRx Limited: 10-Q filed 2023-11-14

What VolitionRx Limited reported in its quarterly report filed 2023-11-14 (fiscal Q3 2023): 42 published measures, 118 facts as tagged in accession 0001477932-23-008451.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-14
Fiscal period
fiscal Q3 2023
Accession
0001477932-23-008451 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VolitionRx Limited filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-3018,040,868USD
At 2022-12-3118,295,054USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-3020,892,177USD
At 2022-12-3121,422,016USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-30-2,042,792USD
At 2022-12-31-2,574,991USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-3010,808,747USD
At 2022-12-3110,867,050USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-8,453,188USD92
2023-01-01 to 2023-09-30-26,877,374USD273
2023-04-01 to 2023-06-30-9,551,277USD91
2023-01-01 to 2023-03-31-8,872,909USD90
2022-07-01 to 2022-09-30-7,812,271USD92
2022-01-01 to 2022-09-30-23,262,281USD273
2022-04-01 to 2022-06-30-7,732,003USD91
2022-01-01 to 2022-03-31-7,718,007USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-24,510,735USD273
2022-01-01 to 2022-09-30-9,474,055USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-30775,027USD273
2022-01-01 to 2022-09-30991,430USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-07-01 to 2023-09-30165,211USD92
2023-01-01 to 2023-09-30531,329USD273
2022-07-01 to 2022-09-3032,714USD92
2022-01-01 to 2022-09-30186,677USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-3025,212,215USD273
2022-01-01 to 2022-09-306,012,068USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-775,027USD273
2022-01-01 to 2022-09-30-991,430USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-193,878,257USD
At 2022-12-31-167,257,429USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-305,304,805USD
At 2022-12-315,393,012USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-07-01 to 2023-09-30537,980USD92
2023-01-01 to 2023-09-301,823,811USD273
2023-04-01 to 2023-06-30592,174USD91
2023-01-01 to 2023-03-31693,657USD90
2022-07-01 to 2022-09-30639,075USD92
2022-01-01 to 2022-09-302,408,410USD273
2022-04-01 to 2022-06-30854,304USD91
2022-01-01 to 2022-03-31915,031USD90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-8,653,055USD92
2023-01-01 to 2023-09-30-27,247,121USD273
2022-07-01 to 2022-09-30-7,992,956USD92
2022-01-01 to 2022-09-30-23,769,408USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-3012,197,319USD
At 2022-12-3112,172,145USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-3017,654,144USD
At 2022-12-3117,386,087USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-303,059,844USD
At 2022-12-313,043,008USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-09-3048,276USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-09-3034,441USD
At 2022-12-3172,609USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2023-01-01 to 2023-09-3031,772USD273
2022-01-01 to 2022-09-300USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-308,818,266USD92
2023-01-01 to 2023-09-3027,778,450USD273
2022-07-01 to 2022-09-308,025,670USD92
2022-01-01 to 2022-09-3023,956,085USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-07-01 to 2023-09-304,650,658USD92
2023-01-01 to 2023-09-3015,007,623USD273
2022-07-01 to 2022-09-304,002,212USD92
2022-01-01 to 2022-09-3011,202,902USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-3078,342,417shares
At 2022-12-3157,873,379shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-09-3010,808,747USD
At 2022-12-3110,867,050USD
At 2022-09-3016,416,069USD
At 2021-12-3120,581,313USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-30191,517,500USD
At 2022-12-31164,397,468USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-09-30239,622USD
At 2022-12-31227,097USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-09-30-2,851,309USD
At 2023-06-305,118,175USD
At 2023-03-31-2,981,145USD
At 2022-12-31-3,126,962USD
At 2022-09-302,839,828USD
At 2022-06-304,079,102USD
At 2022-03-3110,810,692USD
At 2021-12-3117,722,105USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-30490,468USD
At 2022-12-31619,392USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2023-09-303,344,393USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-09-309,071,678USD
At 2022-12-318,705,875USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-09-303,766,873USD
At 2022-12-313,312,863USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2023-09-3048,276USD
At 2022-12-31110,505USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-09-302,867,610USD
At 2022-12-312,872,247USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-8,453,188USD92
2023-01-01 to 2023-09-30-26,877,374USD273
2022-07-01 to 2022-09-30-7,812,271USD92
2022-01-01 to 2022-09-30-23,262,281USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-8,421,897USD92
2023-01-01 to 2023-09-30-26,864,849USD273
2022-07-01 to 2022-09-30-7,741,244USD92
2022-01-01 to 2022-09-30-23,095,061USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-302,599,908USD92
2023-01-01 to 2023-09-307,826,568USD273
2022-07-01 to 2022-09-302,498,506USD92
2022-01-01 to 2022-09-307,855,184USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-01-01 to 2023-09-30792,232USD273
2022-01-01 to 2022-09-30624,830USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-01-01 to 2023-09-3063,715USD273
2022-01-01 to 2022-09-3062,286USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-07-01 to 2023-09-30199,867USD92
2023-01-01 to 2023-09-30369,747USD273
2022-07-01 to 2022-09-30180,685USD92
2022-01-01 to 2022-09-30507,127USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-30163,623USD273
2022-01-01 to 2022-09-30115,860USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-09-3025,868,720USD273
2022-01-01 to 2022-09-305,954,650USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-3034,441USD273
2022-01-01 to 2022-09-30-6,960USD273

Inspect the source

Entity
VolitionRx Limited / CIK 0000093314
Captured
2026-09-19T14:52:44.598Z
SEC response SHA-256
254eb18dbeb68035bca746c45eba900407d99a5725acd9eefccf66cdb02b0404

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000093314.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))